IP Library Granted Patent US 10,350,295
Granted Patent B2
US 10,350,295 · App. 14/916,477 · Granted Jul 16, 2019

Radiopaque polymers

Inventors: Stéphane Hohn (The Hague, NL); Andrew Lennard Lewis (Camberley, GB); Sean Leo Willis (Camberley, GB); Matthew R. Dreher (West Conshohocken, PA); Koorosh Ashrafi (Camberley, GB); Yiqing Tang (Camberley, GB)
Assignee: BIOCOMPATIBLES UK LTD.
A61K47/34A61K31/404A61K31/44A61K31/4745A61K31/517A61K31/555A61K31/704A61K49/048A61K49/0442A61K49/0457
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,350,295
App. No.
14/916,477
Granted
Jul 16, 2019
Kind
B2
Abstract

Radiopaque hydrogels, in particular radiopaque hydrogel microspheres, comprising a polymer having 1,2-diol or 1,3-diol groups acetalized with radiopaque species.

Claims (26)

1. A cross linked hydrogel polymer comprising polyvinyl alcohol (PVA) comprising 1,3-diol groups that are acetalised with a radiopaque species, according to the general formula I:

wherein X is a group of the formula:

wherein:

Z is a linking group bonded to the cyclic acetal, or is absent, such that the phenyl group is bonded to the cyclic acetal, if Z is present, then Z is C 1-6 alkylene, C 1-6 alkoxylene or C 1-6 alkoxyalkylene,

Hal is 1,2,3 or 4 covalently attached iodines.

2. A crosslinked hydrogel polymer according to claim 1 wherein the polymer comprises greater than 20% iodine by dry weight.

3. A crosslinked hydrogel polymer according to claim 1 wherein the polymer is in the form of microparticles or microspheres.

4. A crosslinked hydrogel polymer according to claim 3 wherein the polymer is in the form of microspheres with a mean diameter size range of from 10 to 2000μm.

5. A crosslinked hydrogel polymer according to claim 1 wherein the polymer has a net charge at pH 7.4.

6. A composition comprising a crosslinked hydrogel polymer according to claim 1 and a therapeutic agent wherein the therapeutic agent is absorbed into the polymer matrix.

7. A composition according to claim 6 wherein the therapeutic agent is electrostatically held in the hydrogel polymer and elutes from the polymer in electrolytic media.

8. A crosslinked hydrogel polymer according to claim 1 wherein the phenyl group is substituted by 3 or 4 iodines.

9. A crosslinked hydrogel polymer according to claim 1 wherein the polymer comprises greater than 30% iodine by dry weight.

10. A crosslinked hydrogel polymer according to claim 9 wherein the polymer comprises from 30% to 50% iodine by dry weight.

11. A crosslinked hydrogel polymer according to claim 1 wherein Z is a methylene or ethylene group or is a group (CH 2 ) p —O—(CH 2 ) q — wherein q is 0, 1 or 2 and p is 1 or 2 or is absent.

12. A crosslinked hydrogel polymer according to claim 1 wherein, Z is —(CH 2 ) 2 O(CH 2 ) 2 —, —CH 2 OCH 2 —, —(CH 2 ) 2 O—, —CH 2 O— or is absent.

13. A crosslinked hydrogel polymer according to claim 1 wherein Hal is 3 or 4 iodines.

14. A crosslinked hydrogel polymer according to claim 1 wherein Hal is 2,3,5 triiodo, 2,4,6 triiodo or 2,3,4,6 tetraiodo.

15. A crosslinked hydrogel polymer according to claim 1 wherein the polymer comprises greater than 10% iodine by dry weight.

16. A crosslinked hydrogel polymer comprising PVA and comprising 1,3-diol groups of the PVA that are acetalised with a radiopaque species, such that the hydrogel polymer comprises groups according to the general formula I:

wherein X is an iodinated aryl group.

17. A crosslinked hydrogel polymer according to claim 16 wherein X is an iodinated phenyl group.

18. A crosslinked hydrogel polymer comprising PVA and comprising 1,3-diol groups of the PVA that are acetalised with a radiopaque species, such that the hydrogel polymer comprises groups according to any of the general formulas Ia to Ie

19. A crosslinked hydrogel polymer according to claim 1 in which the polymer is a homopolymer of PVA, a copolymer of PVA or a graft polymer of PVA.

20. A crosslinked hydrogel polymer according to claim 16 in which the polymer is a homopolymer of PVA, a copolymer of PVA or a graft polymer of PVA.

21. A crosslinked hydrogel polymer according to claim 18 in which the polymer is a homopolymer of PVA, a copolymer of PVA or a graft polymer of PVA.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2023
From: BIOCOMPATIBLES UK LIMITED
To: BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
Reel/Frame 065533/0152 →
EMPLOYMENT AGREEMENT Recorded Aug 2, 2016
From: HOHN, STÉPHANE
To: BIOCOMPATIBLES UK LTD
Reel/Frame 039627/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2016
From: LEWIS, ANDREW LENNARD; WILLIS, SEAN LEO; DREHER, MATTHEW; ASHRAFI, KOOROSH; TANG, YIQING
To: BIOCOMPATIBLES UK LTD
Reel/Frame 039280/0579 →
Priority Claims (1)
GB 1315923.1 · Sep 6, 2013 · national
Continuity (1)
Related Publication 20160228556A1 · Aug 11, 2016